
1. curr opin infect dis. 2008 jun;21(3):298-303. doi: 10.1097/qco.0b013e3282fe1bb2.

hepatitis b: modern concepts pathogenesis--apobec3 cytidine deaminases as
effectors innate immunity hepatitis b virus.

bonvin m(1), greeve j.

author information: 
(1)department clinical research, switzerland, university berne, berne,
switzerland.

purpose review: apobec3 editing enzymes inhibit retroviruses cytidine
deamination minus-strand cdna, leading g hypermutated proviruses, 
by less well characterized inhibition retroviral replication independently 
catalysis. review focuses effects apobec3 enzymes the
pararetrovirus hepatitis b virus.
recent findings: cytidine deaminases apobec3b, apobec3c, apobec3f and
apobec3g deaminate cytidine residues hepatitis-b-virus minus-strand cdna,
resulting g hypermutated genomes serum of
hepatitis-b-virus-infected patients. apobec3b, apobec3f apobec3g directly
inhibit hepatitis-b-virus reverse transcription independently deaminase
activity. human liver, apobec3b, apobec3f apobec3g expressed low
levels, human primary hepatocytes stimulated interferon-alpha,
apobec3g induced levels sufficient hepatitis-b-virus inhibition.
apobec3b inhibits hepatitis-b-virus gene transcription, apobec3b apobec3g
preferentially mutate hepatitis-b-virus x gene leading truncated
hepatitis-b-virus x variants hepatitis-b-virus-associated liver cancer.
summary: interferon-inducible apobec3g apobec3s restrict
hepatitis b virus cytidine deamination hepatitis-b-virus minus-strand cdna 
and direct inhibition hepatitis-b-virus reverse transcriptase. nuclear 
localized apobec3b implicated liver cancer development. extent
these enzymes contribute noncytolytic clearance hepatitis b virus vivo
remains defined, yet apobec3 cytidine deaminases likely play a
role processes.

doi: 10.1097/qco.0b013e3282fe1bb2 
pmid: 18448976  [indexed medline]

